US Continuous Glucose Monitoring Market Projected to Grow at 18.51% CAGR by 2030, Supported by Product Innovations and Increased Patient Awareness | DataM Intelligence

Leander, Texas and TOKYO, Japan - The United States Continuous Glucose Monitoring (CGM) Market is estimated to be valued at approximately USD 6.28 billion in 2025 and is projected to reach around USD 14.69 billion by 2030, growing at a CAGR of 18.51% during the forecast period 2025-2030.

This market growth is driven by the increasing prevalence of diabetes in the U.S., advancements in CGM technology improving accuracy and usability, broader insurance coverage including Medicare expansion, and rising awareness among patients and healthcare providers.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/continuous-glucose-monitoring-market?ram

United States: Key Industry Developments

✅ November 2025: Dexcom announced an upgrade to its G7 continuous glucose monitoring system, featuring improved sensor longevity and enhanced integration with popular insulin pumps, aiming to boost user convenience and accuracy in glucose monitoring for diabetic patients.

✅ September 2025: Abbott launched the FreeStyle Libre 4, a next-generation CGM with extended sensor wear time, factory calibration, and real-time data sharing capabilities, enhancing usability for both Type 1 and Type 2 diabetes patients.

✅ June 2025: Medtronic released the Guardian Connect 2, a CGM system incorporating AI-powered predictive alerts to help users avoid hypo- and hyperglycemic events, with improved sensor accuracy and smartphone app connectivity.

Asia Pacific / Japan: Key Industry Developments

✅ October 2025: Japanese company Terumo announced the launch of a new implantable CGM device designed for long-term glucose monitoring, with a focus on biocompatibility and ease of use, targeting both clinical and home-care markets.

✅ August 2025: Panasonic Healthcare introduced its latest wearable CGM sensor with increased battery life and data integration features compatible with Japanese healthcare platforms, aiming at expanding diabetes management tools.

✅ May 2025: Japan's national health insurance began broader coverage for advanced CGM devices, including imports, facilitating easier access for diabetic patients and promoting the adoption of real-time glucose monitoring technologies.

Key Mergers and Acquisitions:

✅ Abbott acquired a health tech AI startup specializing in predictive analytics for CGM data, enhancing its ecosystem with advanced diabetes management tools and expanded geographic market access.

✅ Roche invested $550 million in expanding its manufacturing facilities for CGM systems in the US, strengthening its production capacity and supply chain for the next generation of glucose monitoring devices.

✅ Medtronic partnered with Dexcom in strategic alliances facilitating integrated insulin delivery and CGM data-sharing platforms, reflecting industry consolidation and collaboration trends to offer seamless diabetes care solutions.

Growth Drivers:

-Rising global prevalence of diabetes driven by aging populations, sedentary lifestyles, and obesity increases demand for glucose monitoring devices.

-Technological advancements including smaller, durable sensors, wireless connectivity, and integration with mobile apps improving user experience and real-time monitoring.

-Government initiatives and subsidies enhancing accessibility and affordability of CGM devices worldwide, especially in North America and Asia Pacific.

-Increasing awareness of diabetes management benefits and rising healthcare expenditure supporting adoption.

-Growing elderly population and higher diabetes incidence in emerging markets such as China and India accelerating market expansion.

-Expansion of telehealth and remote monitoring technologies boosting demand for continuous glucose data to aid personalized treatment and prevent complications.

Purchase this report before year-end and unlock an exclusive 30% discount: https://www.datamintelligence.com/buy-now-page?report=continuous-glucose-monitoring-market?ram (Purchase 2 or more Reports and get 50% Discount)

Market Segmentation Analysis:

-By Component

Transmitter: Sends glucose data wirelessly to the receiver or smartphone.

Receiver: Displays real-time glucose readings, often integrated with mobile devices.

Sensor: Implanted or worn on the skin to continuously measure glucose levels.

Insulin Pumps: Devices delivering insulin based on CGM data for automated diabetes management.

Others: Accessories and wearable integration devices.

-By End User

Diagnostics Centers: Use CGM for comprehensive diabetes diagnostics and monitoring.

Intensive Care Units (ICUs): Monitor critically ill patients' glucose levels for tight glycemic control.

Home Healthcare: Largest segment with growing adoption for daily diabetes management by patients.

Regional Insights:

North America: North America dominates the continuous glucose monitoring (CGM) market, driven by high diabetes prevalence, advanced healthcare infrastructure, and strong government support. The United States and Canada lead adoption with ongoing innovation in wearable devices, real-time glucose monitoring, and AI-driven analytics improving diabetic care. Presence of key players and robust reimbursement policies further bolster growth.

Asia-Pacific: This region is expected to register the fastest growth, fueled by rising diabetes incidence, growing geriatric population, and expanding healthcare access. Countries like China, Japan, South Korea, and India are spearheading adoption through increased healthcare investments, technological advancements, and digital health initiatives, especially in emerging urban centers.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/continuous-glucose-monitoring-market?ram

Competitive Landscape:

According to DataM Intelligence, the United States Continuous Glucose Monitoring (CGM) Market is valued at approximately USD 12.69 billion in 2025 and is projected to reach USD 54.55 billion by 2035, growing at a CAGR of 15.7%.

Key Players:
Dexcom Inc | A. Menarini Diagnostics s.r.l | Echo Therapeutics Inc | GlySens Incorporated | Johnson and Johnson

Key Highlights (Top 5 Key Players) for United States Continuous Glucose Monitoring Market:

-Dexcom Inc leads with advanced sensor technology, including the recently FDA-cleared G7 system offering extended wear and improved accuracy.

-A. Menarini Diagnostics s.r.l provides comprehensive diagnostic solutions integrating CGM for diabetes management.

-Echo Therapeutics Inc focuses on innovative, non-invasive CGM technologies aimed at enhancing patient convenience.

-GlySens Incorporated develops implantable CGM sensors providing long-term continuous glucose data.

-Johnson and Johnson offers a broad portfolio of diabetes care products, integrating CGM systems with insulin delivery devices.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?ram

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.